Dashboard
Manage Tickers

STXSStereotaxis, Inc.

NYSE stereotaxis.com


$ 2.13 $ -0.08 (-3.65 %)    

Friday, 06-Sep-2024 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 2.11
$ 2.12 x 100
-- x --
-- - --
$ 1.40 - $ 3.29
167,223
na
178.62M
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-15-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-09-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-10-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-12-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-16-2020 12-31-2019 10-K
20 11-14-2019 09-30-2019 10-Q
21 08-09-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-15-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-14-2018 03-31-2018 10-Q
27 03-20-2018 12-31-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-10-2017 06-30-2017 10-Q
30 05-10-2017 03-31-2017 10-Q
31 03-16-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-10-2016 06-30-2016 10-Q
34 05-11-2016 03-31-2016 10-Q
35 03-11-2016 12-31-2015 10-K
36 11-05-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 03-16-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stereotaxis-q2-2024-gaap-eps-007-misses-005-estimate-sales-4502m-miss-5625m-estimate
Stereotaxis Q2 2024 GAAP EPS $(0.07) Misse...
08/12/2024 20:10:15

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) b...

stereotaxis-achieves-ce-mark-in-europe-and-submits-510k-to-fda-for-genesisx-robotic-system
Stereotaxis Achieves CE Mark In Europe And...
08/12/2024 20:03:51

hyliion-holdings-and-3-other-penny-stocks-insiders-are-buying
Hyliion Holdings And 3 Other Penny Stocks ...
06/18/2024 12:10:50

stereotaxis-announces-penn-presbyterian-medical-center-first-treats-first-heart-rhythm-patients-using-genesis-robotic-magnetic-navigation-system
Stereotaxis Announces Penn Presbyterian Me...
05/29/2024 12:30:47

stereotaxis-receives-ce-mark-recertification-under-eus-medical-device-regulation-regulatory-framework
Stereotaxis Receives CE Mark Recertificati...
05/24/2024 12:38:22

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

stereotaxis-announces-first-heart-rhythm-patients-treated-with-robotic-ablation-procedures
Stereotaxis Announces First Heart Rhythm P...
05/22/2024 12:45:57

stereotaxis-invited-by-africa-heart-rhythm-association-to-present-its-robotic-solution-to-expand-high-quality-therapy-in-africa
Stereotaxis Invited By Africa Heart Rhythm...
05/15/2024 13:14:16

Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, tod...

stereotaxis-q1-2024-gaap-eps-006-inline-sales-6880m-miss-7000m-estimate
Stereotaxis Q1 2024 GAAP EPS $(0.06), Inli...
05/13/2024 20:17:49

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 14.2...

stereotaxis-signs-definitive-agreement-to-acquire-access-point-technologies
Stereotaxis Signs Definitive Agreement To ...
05/13/2024 20:02:59

lake-street-maintains-buy-on-stereotaxis-raises-price-target-to-4
Lake Street Maintains Buy on Stereotaxis, ...
03/05/2024 17:11:29

Lake Street analyst Frank Takkinen maintains Stereotaxis (AMEX:STXS) with a Buy and raises the price target from $3 to $4.

roth-mkm-reiterates-buy-on-stereotaxis-maintains-5-price-target
Roth MKM Reiterates Buy on Stereotaxis, Ma...
03/05/2024 15:23:05

Roth MKM analyst Jason Wittes reiterates Stereotaxis (AMEX:STXS) with a Buy and maintains $5 price target.

stereotaxis-anticipates-double-digit-revenue-growth-for-full-year-2024-sees-q1-revenue-of-7m-est-670m
Stereotaxis Anticipates Double Digit Reven...
03/04/2024 22:22:03

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/04/2024 21:32:25

recap-stereotaxis-q4-earnings
Recap: Stereotaxis Q4 Earnings
03/04/2024 21:10:11

stereotaxis-says-regulatory-submissions-were-made-recently-in-both-europe-and-us-for-magic-catheter
Stereotaxis Says Regulatory Submissions We...
03/04/2024 21:08:36

stereotaxis-q4-2023-gaap-eps-0070-inline-sales-4565m-miss-7700m-estimate
Stereotaxis Q4 2023 GAAP EPS $(0.070), Inl...
03/04/2024 21:07:03

Stereotaxis (AMEX:STXS) reported quarterly losses of $(0.070) per share which met the analyst consensus estimate. The company ...

earnings-scheduled-for-march-4-2024
Earnings Scheduled For March 4, 2024
03/04/2024 09:53:45

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

earnings-preview-for-stereotaxis
Earnings Preview For Stereotaxis
03/01/2024 15:01:36

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/12/2024 13:05:59

roth-mkm-initiates-coverage-on-stereotaxis-with-buy-rating-announces-price-target-of-5
Roth MKM Initiates Coverage On Stereotaxis...
01/10/2024 12:05:48

Roth MKM analyst Jason Wittes initiates coverage on Stereotaxis (AMEX:STXS) with a Buy rating and announces Price Target of $5.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION